Medical Care Technologies (OTC PINK:MDCE) Advances First AI-Powered Mobile Application Toward Launch on Google Play and Apple App Store

MESA, AZ / ACCESS Newswire / December 19, 2025 / Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced that its first-ever AI-powered mobile application has entered final review stages on both major mobile platforms.

The Company confirmed that its inaugural AI-driven consumer application is currently in Google Play Console Developer Testing and has also entered official testing within Apple’s App Store ecosystem, marking a major milestone as the Company approaches the launch of its first mobile app.

This first AI application was developed in the food and nutrition sector, a category chosen for its broad global appeal and wide marketability, as it can be used by most people of cooking age worldwide. Management believes this positioning gives the Company strong revenue potential for its initial AI product while establishing a foundation for future applications.

“Our first AI app targets the food and nutrition space because it’s a massive, global market measured in the hundreds of billions of dollars and touches nearly every household,” said Marshall Perkins, CEO of Medical Care Technologies. “This gives us immediate scale and revenue potential while we continue developing additional AI-driven health, wellness, and medical pre-screening applications. These are real milestones, real progress, and we’re excited about where this positions the Company heading into 2026.”

The Company views this launch as the first step in a broader AI strategy that includes future consumer health and wellness applications, as well as more advanced AI-powered medical pre-screening technologies currently under development and testing.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC Pink: MDCE) is a technology company focused on developing artificial intelligence-powered applications across consumer, health, wellness, and medical sectors. The Company is building a scalable AI ecosystem designed to address large, global markets with data-driven solutions.
For more information, visit www.medicalcaretechnologies.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially, including platform review outcomes, launch timing, market acceptance, and general business conditions. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

9 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

9 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago